Study Provides Insight Into How the Brain Loses Plasticity of Youth

Intriguingly, brains of immature PirB-deprived mice also exhibited greater plasticity than brains endowed with the protein. Taken together, the results have important implications for the future study and repair of the brain. “Our study of mutant mice lacking PirB function reveals that at all ages, even during critical periods when circuits are prone to change, there are active molecular mechanisms that function to limit synaptic plasticity,” said Josh Syken, HMS instructor in neurobiology and lead author of the study.

One way to promote new connections in brains damaged by disease or injury might be to target PirB. “The implications here should attract broad interest outside the field of developmental neuroscience because molecules and mechanisms that oppose neuronal plasticity represent new targets for therapy to re-establish damaged connections following spinal cord injury, head injury or stroke,” said Syken, who carried out the study with Carla Shatz, Nathan Marsh Pusey professor of neurobiology at HMS, and colleagues.

Plasticity, the ability of functional brain circuits to change in response to experience-dependent neuronal activity, is largely restricted to critical periods of development. In their classic Nobel-prize winning experiments, David Hubel and Torsten Weisel showed that visual areas of the brain are responsive to environmental cues during a discrete period early in life, after which they do not change. Researchers have successfully identified proteins that promote such critical periods of plasticity but less is known about the proteins that stabilize neuronal connections.

Several years ago, Shatz and colleagues made the surprising discovery that MHC Class I genes are turned on in neurons by neuronal activity and in fact are required for normal synaptic plasticity. In the immune system, MHC Class I proteins teach immune cells which cells to attack. They do this by interacting with a large number of receptors found on the surface of immune cells. Syken, Shatz and colleagues wondered whether such receptors might also be expressed in neurons and involved in MHC Class I-mediated synaptic plasticity.

Using a method called in situ hybridization, they found that the MHC Class I receptor PirB is expressed widely throughout the brain and at all ages. To see how PirB was functioning, they generated a mouse deficient in PirB. At first sight, the mutant’s brain appeared normal. To get a better sense of how PirB might be affecting plasticity, they decided to focus on the visual cortex.

In their earlier work, Hubel and Weisel showed that suturing or removing one eye causes projections from the remaining eye to invade the area that normally represents the blocked eye. This shift is strictly limited to a critical period of development early in life. Syken and his colleagues sutured one eye in their adult mutant mice, and also in controls, for several days. They exposed the open eye to light and, using the activity-sensitive gene Arc as their guide, looked to see which neurons in the cortex were activated. The PirB mutant adults exhibited a robust expansion of the area in visual cortex that responds to the open eye, suggesting that new connections representing the open eye had formed. They repeated the experiment with younger mice and found, somewhat unexpectedly, that plasticity was enhanced even during the immature period.

“Other factors have been shown to restrict plasticity after the critical period, but we believe that this is one of the first proteins shown to act in this way throughout life,” Syken said. “Our discovery implies that there are mechanisms that enable, and also those that oppose synaptic plasticity in a push-pull fashion.”

“Our discovery underscores further the fascinating and common molecular parallels between the nervous system and the immune system, where PirB was first studied. The discovery of a neuronal receptor for MHC Class I opens up a completely new avenue for thinking about broader roles for this family of molecules beyond the immune system,” he said.

Source: Harvard Medical School

Reprogrammable cell type depends on a single gene to keep its identity
Scientists at St. Jude Children's Research Hospital have discovered that a certain differentiated cell type is so ready to change its identity that it requires the constant expression of a gene called Prox1 to dissuade it.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.
Protein in embryonic stem cells control malignant tumor cells
A protein that governs development of human embryonic stem cells (hESCs) also inhibits the growth and spread of malignant melanoma, the deadliest skin cancer, Northwestern University researchers have discovered. Metastatic melanoma, which develops from the transformation of skin pigment cells or melanocytes, has a death rate of more than 80 percent and a median survival of less than 7.5 months.
Polluted prey causes wild birds to change their tune
Considerable attention has been paid to the effects of endocrine disrupting chemicals in aquatic environments, but rather less attention has been given to routes of contamination on land. A new study, published in PLoS ONE on February 27 by researchers at Cardiff University, reveals that wild birds foraging on invertebrates contaminated with environmental pollutants, show marked changes in both brain and behaviour: male birds exposed to this pollution develop more complex songs, which are actually preferred by the females, even though these same males usually show reduced immune function compared to controls.
Fat kills cancer
Researchers in Slovakia have been able to derive mesenchymal stem cells from human adipose, or fat, tissue and engineer them into “suicide genes” that seek out and destroy tumors like tiny homing missiles. This gene therapy approach is a novel way to attack small tumor metastases that evade current detection techniques and treatments, the researchers conclude in the July 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Reversing cancer cells to normal cells
A Northwestern University scientist describes new research that used an innovative experimental approach to provide unique insights into how scientists can change human metastatic melanoma cells back to normal-like skin cells -- by exposing the tumor cells to the embryonic microenvironment of human embryonic stem cells, the zebra fish and the chick embryo.
Dendritic cells stimulate cancer-cell growth
Since their discovery at Rockefeller University some 30 years ago, dendritic cells have been recognized as key players on the immune-system team, presenting antigens to other immune cells to help them respond to novel insults. Now, Rockefeller scientists have shown that dendritic cells also have other, non-immune actions, and may in fact directly modify the biology of some types of cancer cells.
Investigators Discover Modified Growth Control in Human Embryonic Stem Cells
Two papers published by University of Massachusetts Medical School (UMMS) Department of Cell Biology and Cancer Center investigators report striking changes in control of growth in human embryonic stem cells. The studies were carried out on a National Institutes of Health funded grant using two of the six federal government approved human embryonic stem cell lines.

Study Provides Insight Into How the Brain Loses Plasticity of Youth

Related stories:

News discussion: